Healthcare technology provider CNSI recently announced a merger with Kepro, a healthcare technology company specializing in care management, clinical assessment services, and quality oversight. The newly joined companies plan to focus on supporting government-sponsored care agencies and payers, empowering them to expand patient access to care, improve health outcomes, lower costs, and improve quality through the use of its provider management, health analytics, claims and encounter processing, and clinical services and solutions.
The new company will be led by Todd Stottlemyer, Chief Executive Officer of CNSI, with Susan Weaver, Kepro’s President and CEO, serving as President. Both executives will also serve on the company’s board of directors. The deal is expected to close in December 2022, and the newly merged company will rebrand in early 2023.
"The combination of CNSI and Kepro aligns with the strategic objectives of both companies to deploy technology-enabled products, solutions, and services that help our clients achieve their mission and better serve their priority populations," said Stottlemyer. "I am excited about our ability to provide a full array of services and solutions that will help our clients meet the holistic health needs of those they serve."
McLean, VA-headquartered CNSI employs more than 1,200 subject matter experts, program managers, and technologists across the globe, providing a wide array of health IT enterprise products and solutions to a diverse base of U.S. state and federal agencies, helping clients reduce costs, enhance business performance, and improve the health of individuals and communities.
The company is backed by funds managed by global investment firm Carlyle, which holds $369 billion in assets under management, deploying private capital across global private equity, global credit, and global investment solutions.
Kepro was founded in 1985 by a group of physicians to provide technology-based services to help patients remain in the home or community of their choice. The company boasts more than 1,700 employees across its 17 U.S.-based offices, along with a network of 4,500 physicians and 600 full-time clinicians, partnering with public and private healthcare payers to improve accuracy, increase efficiency, and maximize healthcare quality. Kepro is a portfolio company of Apax Partners LLP, which will exit its investment through the transaction.